Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin

NCT01818141 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Clostridium Difficile Infection

Interventions

DRUG: Vancomycin
DRUG: Fidaxomicin

Sponsor

Hartford Hospital

Collaborators

[object Object]